Carbenoxolone
ALIMENTARY TRACT AND METABOLISM
Also known as: biogastrone, carbenoxolone disodium, carbenoxolone disodium salt, carbenoxolone sodium, glycyrrhetinic acid hydrogen succinate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Carbenoxolone is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including Hsd11b2, HSD11B1 and Hsd11b1. Recorded indications include Peptic ulcer and Ulcer of esophagus.
- Molecular targets: Hsd11b2, HSD11B1, Hsd11b1 and Panx1 (4 listed in DrugCentral).
- Indications: Peptic ulcer and Ulcer of esophagus.
- ATC code: A02BX01 (Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)).
- Molecular formula: C34H50O7; molecular weight 570.77 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Peptic ulcer
- Ulcer of esophagus
Mechanism & targets
Molecular targets (4)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Corticosteroid 11-beta-dehydrogenase isozyme 2 | Hsd11b2 | unknown | IC50 7.09 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | HSD11B1 | inhibitor | IC50 7.08 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Hsd11b1 | unknown | IC50 6.97 |
| Pannexin-1 | Panx1 | unknown | IC50 5.00 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
A02BX01 | ALIMENTARY TRACT AND METABOLISM › DRUGS FOR ACID RELATED DISORDERS › DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) › Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
A02BX51 | ALIMENTARY TRACT AND METABOLISM › DRUGS FOR ACID RELATED DISORDERS › DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) › Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
A02BX71 | ALIMENTARY TRACT AND METABOLISM › DRUGS FOR ACID RELATED DISORDERS › DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) › Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Carbenoxolone is on its molecule page.
| Molecular formula | C34H50O7 |
|---|---|
| Molecular weight | 570.77 g/mol |
| CAS number | 5697-56-3 |
| InChIKey | OBZHEBDUNPOCJG-WBXJDKIVSA-N |
| PubChem CID | 636403 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Carbenoxolone used for?
DrugCentral lists the following indications for Carbenoxolone: Peptic ulcer and Ulcer of esophagus.
How does Carbenoxolone work?
Its molecular targets in DrugCentral include Hsd11b2, HSD11B1 (inhibitor), Hsd11b1 and Panx1.
What is the chemical formula of Carbenoxolone?
Carbenoxolone has the molecular formula C34H50O7 and a molecular weight of 570.77 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 493 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1697717 — compound record and bioactivity
- PubChem CID 636403 — chemical identifiers
- DrugBank DB02329 — drug record
- FDA UNII MM6384NG73 — substance identity
- UniProt P28845 (HSD11B1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.